Omnium News
Live story

What does the evidence establish about vaccines and autism?

Confidence as of August 4, 2026

3 claims2 open questions

Our take

The paper that started the autism-vaccine claim was retracted. Large studies since have not found a causal link.

Why we say this

This story tracks the evidence regarding claims that routine childhood vaccines cause autism spectrum disorder. The question became widely public after a 1998 Lancet paper that was later retracted. Subsequent epidemiological studies, systematic reviews, and official health agency assessments have extensively examined the claim.

Where things stand

The original paper proposing a link was retracted and its lead author lost his medical license over research misconduct. Large epidemiological studies and major reviews have not found a causal relationship between vaccines such as MMR and autism, although public concern persists and unrelated claims about other vaccines or ingredients are sometimes discussed separately.

Sign in coming soon

Omnium News is still being refined, but soon you'll be able to sign up to follow the stories that matter to you — and be notified when substantial new information is available.

If staying current and informed is important to you, we can email you when sign in goes live.

We'll only use this to tell you when sign in is available. No other mail.

Soon you'll be able to follow a story and get notified when the evidence changes.

Confidence

as of August 4, 2026

The strongest artifacts include the retracted Wakefield paper itself, large population studies (including a 2026 U.S. EHR cohort of about 2.5 million children), the Institute of Medicine review, and CDC vaccine safety summaries. These sources do not establish that vaccines cause autism. Claims about specific vaccine components such as thimerosal or newer vaccines may require separate evaluation, but the central MMR-autism hypothesis has been extensively tested and not corroborated.

This is our best read given the published evidence we have reviewed — not a claim of absolute truth.

Open questions

  • How should rare adverse events be monitored as vaccine schedules change?

    Routine surveillance continues even when major causal claims are not supported.

  • How should public trust be rebuilt when a retracted study had outsized influence?

    The history of this claim affects how later vaccine evidence is received.

What would change our mind

  • Multiple independent high-quality studies consistently demonstrating a causal relationship between routine childhood vaccines and autism.
  • New authenticated evidence showing that major existing reviews systematically misclassified or omitted relevant cases.

Timeline — How we got here

4 updates · append-only
  1. New evidenceLarge U.S. EHR cohort finds no MMR–autism link before age 2

    Burstain and colleagues analyzed Cosmos electronic health records for more than 2.5 million U.S. children and found no association between receiving the first MMR dose from ages 11.5 to 24 months and a later autism diagnosis — reinforcing earlier epidemiological evidence against an MMR–autism causal link.

Claims & evidence

Each claim is tracked separately — not a single verdict.

What this doesn’t establish

Claims commonly associated with this story that the available evidence does not establish. Confirming a narrow fact here is not confirmation of the broader narrative around it. As such, these claims are not included in the claims bar above.

  • Because the Wakefield paper was retracted, every possible vaccine safety concern about every vaccine is disproved.

    Evidence basis

Help improve this story

Point us at a source, a mistake, or a framing problem. Every submission is reviewed by a human before anything changes — this is not a vote on what’s true.

Required — primary docs, official statements, datasets, filings, etc.

Confidence last reviewed August 4, 2026. Updates are append-only; nothing here is edited silently.

Sign in coming soon

Omnium News is still being refined, but soon you'll be able to sign up to follow the stories that matter to you — and be notified when substantial new information is available.

If staying current and informed is important to you, we can email you when sign in goes live.

We'll only use this to tell you when sign in is available. No other mail.

Soon you'll be able to follow a story and get notified when the evidence changes.